The global GLP-1 drugs market is entering a new phase of expansion as demand shifts beyond traditional diabetes treatment ...
Results from the global Phase 3 ALKIVIA study, the first registrational study investigating an FcRn blocker in autoimmune myositis, show ...
A 3-2-1 countdown sends two classic Porsche 911 Turbos racing from a roll down Utah Motorsports Park’s front straight, the ...
5don MSN
Factbox - Weight-loss drug developers line up to tap lucrative market as competition heats up
Oct 16 (Reuters) - The weight-loss drug market is booming, with biotech firms racing to capture a slice of the fast-growing ...
Novo Nordisk is pressing ahead with obesity and cardiometabolic drug development, including CagriSema regulatory submissions ...
Gilead Sciences has notched a phase 2 win in ulcerative colitis (UC), with its once-daily pill emvistegrast outperforming ...
Ghuge inventions span physical-activity oral airway technology, biometric tracking, controllers, a longer-term vision ...
Veradermics' extended-release oral minoxidil hit primary endpoints in 536 men, increasing hair counts with no serious cardiac ...
Entries will be accepted through November 13, 2026. The ADPH Oral Health Office endorses the benefits of preventive dental visits for children, encourages community water fluoridation, and promotes ...
A sweeping new review maps the two-way molecular conversation between the oral microbiome and the immune system in ...
SUN PRAIRIE, WI, UNITED STATES, October 15, 2026 /EINPresswire.com/ -- First Choice Dental, a leading dental clinic in ...
U.S. biopharmaceutical company Veradermics announced that its extended-release oral minoxidil formulation VDPHL01 met all study goals in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results